期刊文献+

老年人外周血树突状细胞的体外培养及功能研究 被引量:6

Study on the culture and function of dendritic cells derived from the very elderly in vitro
下载PDF
导出
摘要 目的探讨≥80岁老年人外周血单核细胞体外诱导培养生成树突状细胞(dendritic cells,DCs)的情况及其功能特点。方法取30例≥80岁老年人及30例60~70岁老年人外周血,用淋巴细胞分离液离心获得单个核细胞,贴壁培养2 h后获得单核细胞,用含有rhGM-CSF和rhIL-4的培养基培养1周,观察2组DCs的生长、活力、存活时间、同种T淋巴细胞的刺激反应,并进行比较。结果≥80岁组DCs培养过程中细胞逐渐死亡,培养至第7天大部分细胞死亡,获得的DCs数量较少,其中有8例未能培养出DCs;较60~70岁组对同种T淋巴细胞的刺激能力也显著下降,而60~70岁组培养细胞的活力保持较好,至第7天均可获得数量较多的DCs。结论较60~70岁组,≥80岁组外周血培养的DCs体外的生长活力、T细胞刺激能力明显降低,可能是≥80岁老年人免疫功能降低的重要原因。 Objective To investigate the culture and immunologic function of the dendritic cells(DCs) derived from the very elderly in vitro. Methods Peripheral blood was collected from the very elderly ( ≥80 years old, n = 30 ) and the elderly (60-70 years old, n = 30). The mononuelear cells, separated by centrifugalization, were cultured with rhGM-CSF and rhIL-4 for a week, and the growth velocity, vigour, survival time and mixed lymphocytic reaction of DCs were observed. Results In the very elderly, most of the DCs were nonviable at the 7th day after cultured, and no DCs were detected in g subjects. The capacity to stimulate proliferation of allogeneic T lymphocytes was also lower. On the other hand, in the elderly,the DCs grew prosperity in all the subjects. At the 7th day after cultured, DCs could be seen in the every subjects. Conclusions The growth velocity, vigour, survival time, and the capacity to stimulate proliferation of allogeneic T lymphocytes of the DCs are lower in the very elderly than that in the younger elderly, which may be the important reason for the immunological function impairment in the very elderly.
出处 《实用老年医学》 CAS 2009年第4期270-272,F0002,共4页 Practical Geriatrics
基金 南京军区卫生部课题(08MA089)
关键词 ≥80岁老年人 树突状细胞 细胞培养 混合淋巴细胞反应 aged 80 and older dendritic cells cell culture mixed lymphocytic reaction
  • 相关文献

参考文献10

  • 1Katsnelson A. Kicking off adaptive immunity: the discovery of dendritic cells[J]. J Exp Med, 2006,203(7) : 1622.
  • 2Lopez-Bravo M, Ardavin C. In vivo induction of immune responses to pathogens by conventional dendritic ceils [ J ]. Immunity, 2008, 29 (3) : 343-351.
  • 3Wu L, Liu YJ. Development of dendritic-cell lineages [ J ]. Immunity, 2007, 26 (6) :741-750.
  • 4Steinman RM, Banchereau J. Taking dendritic cells into medicine[J]. Nature, 2007,449(7161 ) :419-426.
  • 5Rossi M, Young JW. Human dendritic cells : potent antigenpresenting cells at the crossroads of innate and adaptive immunity[J]. J Immunol, 2005,175(3) : 1373-1381.
  • 6Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha [J]. J Exp Med, 1994, 179(4): 1109-1118.
  • 7朱学军,曹雪涛,于益芝,陈国友,万涛,马施华,唐华,章卫平.人外周血树突状细胞的体外扩增及鉴定[J].中国肿瘤生物治疗杂志,1997,4(4):302-306. 被引量:91
  • 8Romani N, Gruner S, Brang D, et al. Proliferating dendritic cell progenitors in human blood[J]. J Exp Med, 1994, 180 ( 1 ) : 83-93.
  • 9Randolph G J, Angeli V, Swartz MA. Dendritic-cell trafficking to lymph nodes through lymphatic vessels [ J ]. Nat Rev Immunol, 2005,5 ( 8 ) :617-628.
  • 10Agawal A, Agrawal S, Gupta S. Dendritic cells in human aging [ J ]. Exp Gerontol, 2007,42 ( 5 ) :421-426.

共引文献90

同被引文献52

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部